Strides Pharma Science Ltd Share Price
(STAR)
₹641.2▲1.22%
as on 04:01PM, 19 Mar 2025
🔔 Demerger and Acquisition Alert
Strides Pharma to demerge from Arco Labs and acquire 100% stake in Amexel Pte. Ltd. for US $10.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 0.8 % |
3 Month Return | -9.4 % |
1 Year Return | -17.61 % |
Market Stats | |
Previous Close | ₹633.50 |
Open | ₹634.90 |
Volume | 4.32L |
Upper Circuit | ₹760.20 |
Lower Circuit | ₹506.80 |
Market Cap | ₹5,838.51Cr |
P/E Ratio
36.84
PEG Ratio
1.67
Market Cap
₹5,838.51 Cr
P/B Ratio
2.02
EPS
-4.49599698514042
Dividend Yield
0.32
Sector
Pharmaceuticals
ROE
1.87
based on 3 analysts
66.67%
Buy
0.00%
Hold
33.33%
Sell
Based on 3 analysts offering long term price targets for Strides Pharma Science Ltd. An average target of ₹1373
Source: S&P Global Market Intelligence
Strides Pharma Science Ltd price forecast by 3 analysts
Upside of116.73%
High
₹1874
Target
₹1373.00
Low
₹1070
Strides Pharma Science Ltd target price ₹1373, a slight upside of 116.73% compared to current price of ₹641.2. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Strides Pharma Science Ltd revenue growth forecast
Expected growth rate Q1, FY2027:42.39%
Forecast
Actual
Including amortisation and stock based compensations
Strides Pharma Science Ltd EPS growth forecast
EPS estimate Q1, FY2027:
Forecast
Actual
Source: S&P Global Market Intelligence
Today's Timeline - Invalid Date
12:04 PM
-Strides Pharma announces in-principle approval for demerger from Arco Labs, creating a new wholly-owned subsidiary focused on Life Sciences.
Strides Pharma Gains from Singapore Acquisition - 17 Mar, 2025
Strides Pharma Acquires Amexel for Strategic Growth - 15 Mar, 2025
OneSource Seeks Clarification on Regulatory Exemption - 06 Mar, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Up
Promoters have increased holdings from 25.84% to 26.82% in Dec 2024 quarter
MF Holding Up
Mutual Funds have increased holdings from 10.80% to 10.86% in Dec 2024 quarter
Retail Holding Up
Retail Investor have increased holdings from 25.83% to 27.77% in Dec 2024 quarter
Profit Spike
Netprofit is up for the last 4 quarters, 18.18 Cr → 87.95 Cr (in ₹), with an average increase of 31.6% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 67.5% return, outperforming this stock by 85.1%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 126.9% return, outperforming this stock by 47.0%
Revenue Fall
Revenue is down for the last 2 quarters, 1.19K Cr → 1.16K Cr (in ₹), with an average decrease of 2.9% per quarter
FII Holding Down
Foreign Institutions have decreased holdings from 30.08% to 28.48% in Dec 2024 quarter
Price Dip
In the last 6 months, STAR stock has moved down by -52.3%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 26.82% | 3.81 | |
Foreign Institutions | 28.48% | ||
Mutual Funds | 10.86% | 0.57 | |
Retail Investors | 27.77% | 7.48 | |
Others | 6.07% |
Strides Pharma Science Ltd in the last 5 years
Lowest (-409.06x)
July 5, 2021
Today (36.84x)
March 18, 2025
Industry (51.23x)
March 18, 2025
Highest (6306.63x)
September 27, 2024
Strides Pharma Science Ltd’s net profit jumped 77.07% since last year same period to ₹87.95Cr in the Q3 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated 22.42% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Strides Pharma Science Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.62%.
Read More about DividendsBearish
Neutral
Bullish
Strides Pharma Science Ltd is currently in a Neutral trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹5,838.51 Cr | 25.77% | 0.66 | -₹95 Cr | ₹4,051 Cr | |
NA | ₹47.23 Cr | 12.95% | 0.68 | NA | NA | |
NA | ₹115.89 Cr | 84.64% | 0.50 | NA | NA | |
NA | ₹1,439.94 Cr | 549.29% | 0.52 | NA | NA | |
NA | ₹21.77 Cr | 25.86% | 0.52 | NA | NA |
Organisation | Strides Pharma Science Ltd |
Headquarters | Bangaluru |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Strides Pharma Science Ltd share price today stands at ₹641.2, Open: ₹634.9, Previous Close: ₹633.5, High: ₹652, Low: ₹627, 52 Week High: ₹1675, 52 Week Low: ₹530.
Today's traded volume of Strides Pharma Science Ltd(STAR) is 4.32L.
Today's market capitalisation of Strides Pharma Science Ltd(STAR) is ₹5838.51Cr.
Strides Pharma Science Ltd (STAR) share price is ₹641.2. It is down -61.72% from its 52 Week High price of ₹1675
Strides Pharma Science Ltd (STAR) share price is ₹641.2. It is up 20.98% from its 52 Week Low price of ₹530